TY - JOUR
T1 - Bortezomib for the treatment of multiple myeloma
AU - Scott, Kathleen
AU - Hayden, Patrick J.
AU - Howman, Andrew
AU - Wheatley, Keith
AU - Coyne, Imelda
PY - 2013/11/11
Y1 - 2013/11/11
N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: We will assess the effects of bortezomib treatment in comparison to other therapies, different doses, treatment administration and schedules of bortezomib, on overall survival (OS), progression-free survival (PFS), response rate (RR), health-related quality of life (HRQoL), adverse events (AE) and treatment-related death.
AB - This is the protocol for a review and there is no abstract. The objectives are as follows: We will assess the effects of bortezomib treatment in comparison to other therapies, different doses, treatment administration and schedules of bortezomib, on overall survival (OS), progression-free survival (PFS), response rate (RR), health-related quality of life (HRQoL), adverse events (AE) and treatment-related death.
UR - http://www.scopus.com/inward/record.url?scp=85040927338&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD010816
DO - 10.1002/14651858.CD010816
M3 - Article
AN - SCOPUS:85040927338
SN - 1469-493X
VL - 2013
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 11
M1 - CD010816
ER -